1. The Survival Benefit for Optimal Glycemic Control in Advanced Non-Small Cell Lung Cancer Patients With Preexisting Diabetes Mellitus
   Jie Qian et al, 2021, Frontiers in Oncology CrossRef
2. A human-based multi-gene signature enables quantitative drug repurposing for metabolic disease
   James A Timmons et al, 2022, eLife CrossRef
3. The cell line models to study tyrosine kinase inhibitors in non-small cell lung cancer with mutations in the epidermal growth factor receptor: A scoping review
   Alessia Belloni et al, 2024, Critical Reviews in Oncology/Hematology CrossRef
4. Cellular Origins of EGFR‐Driven Lung Cancer Cells Determine Sensitivity to Therapy
   Fan Chen et al, 2021, Advanced Science CrossRef
5. Obesity: a perfect storm for carcinogenesis
   Benjamin H. L. Harris et al, 2022, Cancer and Metastasis Reviews CrossRef